Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer

A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood–brain barrier, and the transporting mechanism to glioma cells

(2017) Chang Liu et al.   International Journal of Nanomedicine

Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model

(2016) Masoumeh Zahmatkeshan et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid

(2016) Shravan Kumar Sriraman et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance

(2016) Elmira Bajelan et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Design of liposomal formulations for cell targeting

(2015) Eugénia Nogueira et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Nanocarriers for cancer-targeted drug delivery

(2015) Preeti Kumari et al.   JOURNAL OF DRUG TARGETING

Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: In vitro and in vivo evaluation

(2014) Ankitkumar S. Jain et al.   BIOMEDICINE & PHARMACOTHERAPY

Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model

(2014) Jia Lin et al.   PLoS One

A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy

(2014) LI QIN et al.   Oncology Letters

The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems

(2014) Stephanie Tortorella et al.   Current Drug Delivery

Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models

(2013) Anjali Apte et al.   CANCER BIOLOGY & THERAPY

Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer

(2013) Swati Biswas et al.   CANCER LETTERS

Arginine-rich Peptides: Methods of Translocation Through Biological Membranes

(2013) Shiroh Futaki et al.   CURRENT PHARMACEUTICAL DESIGN

Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity

(2013) Swati Biswas et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers

(2013) Rakesh K. Jain   JOURNAL OF CLINICAL ONCOLOGY

A simple way to enhance Doxil® therapy: Drug release from liposomes at the tumor site by amphiphilic block copolymer

(2013) Yi Zhao et al.   JOURNAL OF CONTROLLED RELEASE

Nanotechnology in cancer therapy

(2013) Burcu Aslan et al.   JOURNAL OF DRUG TARGETING

The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy

(2013) Rupa R. Sawant et al.   JOURNAL OF DRUG TARGETING

Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization

(2013) Yu Nie et al.   Theranostics

Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes

(2012) Alexander Koshkaryev et al.   CANCER BIOLOGY & THERAPY

Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition

(2012) Alexander Koshkaryev et al.   CANCER LETTERS

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

(2012) Yanti Octavia et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

The transferrin receptor and the targeted delivery of therapeutic agents against cancer

(2011) Tracy R. Daniels et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Pegylated Liposomal Doxorubicin

(2011) Sean T. Duggan et al.   DRUGS

Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery

(2011) Ikramy A. Khalil et al.   JOURNAL OF CONTROLLED RELEASE

Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment

(2009) Ayman El-Sayed et al.   AAPS Journal

Arginine-rich cell-penetrating peptides

(2009) Nathan Schmidt et al.   FEBS LETTERS

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin

(2009) XueMing Li et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Intracellulartransduction using cell-penetrating peptides

(2009) Rupa Sawant et al.   Molecular BioSystems

Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

(2009) C. H. J. Choi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery

(2008) Vladimir P. Torchilin   BIOPOLYMERS